Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer

MacLean, James Malcolm

Back to search

Division of Virology

Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer

dc:creator MacLean, James Malcolm

dc:date.issued2005

Abstract

dc:description.abstract

Includes bibliographical references (leaves 214-236).

Degree

thesis:*

Grantor dc:publisher.institution: Division of Virology
Year dc:date.issued: 2005

Author and committee

dc:creator, dc:contributor.*

Author dc:creator: MacLean, James Malcolm
Advisor dc:contributor.advisor: Williamson, Anna-Lise

Rights

Language dc:language.iso: eng

Identifiers

dc:identifier.*

Handle dc:identifier.uri: http://hdl.handle.net/11427/2730
OAI identifier oai:identifier: oai:open.uct.ac.za:11427/2730

Chain of custody

source

Harvested from: University of Cape Town
Base URL: open.uct.ac.za/oai/request
Last updated: 2026-07-24
Source record: OAI-PMH GetRecord

related terms

citation

MacLean, James Malcolm. Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer. Division of Virology, 2005. http://hdl.handle.net/11427/2730

Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer

Abstract

Degree

Author and committee

Rights

Identifiers

Chain of custody

More from University of Cape Town